These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 9874793)

  • 21. Lineage commitment in the immune system: the T helper lymphocyte grows up.
    Glimcher LH; Murphy KM
    Genes Dev; 2000 Jul; 14(14):1693-711. PubMed ID: 10898785
    [No Abstract]   [Full Text] [Related]  

  • 22. Neurotransmitter signalling via NMDA receptors leads to decreased T helper type 1-like and enhanced T helper type 2-like immune balance in humans.
    Orihara K; Odemuyiwa SO; Stefura WP; Ilarraza R; HayGlass KT; Moqbel R
    Immunology; 2018 Mar; 153(3):368-379. PubMed ID: 28940416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The priming of helper T cells.
    Janeway CA
    Semin Immunol; 1989 Sep; 1(1):13-20. PubMed ID: 15630955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development in motion: helper T cells at work.
    Reiner SL
    Cell; 2007 Apr; 129(1):33-6. PubMed ID: 17418783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients.
    Chen YM; Yang WK; Ting CC; Tsai WY; Yang DM; Whang-Peng J; Perng RP
    Chest; 1997 Oct; 112(4):960-6. PubMed ID: 9377959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effector T helper cell triade.
    Fietta P; Delsante G
    Riv Biol; 2009; 102(1):61-74. PubMed ID: 19718623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-helper (Th)1/Th2 imbalance in the peripheral blood of dogs with malignant tumor.
    Horiuchi Y; Hanazawa A; Nakajima Y; Nariai Y; Asanuma H; Kuwabara M; Yukawa M; Ito H
    Microbiol Immunol; 2007; 51(11):1135-8. PubMed ID: 18037791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical basis of antigen-specific suppressor T cell factors: controversies and possible answers.
    Ishizaka K; Ishii Y; Nakano T; Sugie K
    Adv Immunol; 2000; 74():1-60. PubMed ID: 10605603
    [No Abstract]   [Full Text] [Related]  

  • 29. Selection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancer.
    Watt WC; Cecil DL; Disis ML
    Semin Immunopathol; 2017 Apr; 39(3):245-253. PubMed ID: 27975138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-cell response to allergens.
    Ozdemir C; Akdis M; Akdis CA
    Chem Immunol Allergy; 2010; 95():22-44. PubMed ID: 20519880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of two distinct B cell activation pathways mediated by a monoclonal T helper cell. II. T helper cell secretion of interleukin 4 selectively inhibits antigen-specific B cell activation by cognate, but not noncognate, interactions with T cells.
    Asano Y; Nakayama T; Kubo M; Fujisawa I; Karasuyama H; Singer A; Hodes RJ; Tada T
    J Immunol; 1988 Jan; 140(2):419-26. PubMed ID: 2447177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD2 facilitates differentiation of CD4 Th cells without affecting Th1/Th2 polarization.
    Sasada T; Yang H; Reinherz EL
    J Immunol; 2002 Feb; 168(3):1113-22. PubMed ID: 11801645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T helper subset differentiation in the absence of invariant chain.
    Brown DR; Swier K; Moskowitz NH; Naujokas MF; Locksley RM; Reiner SL
    J Exp Med; 1997 Jan; 185(1):31-41. PubMed ID: 8996239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B lymphocyte activation upon exclusive recognition of major histocompatibility antigens by T helper cells.
    Pobor G; Pettersson S; Bandeira A; Martinez-A C; Coutinho A
    Eur J Immunol; 1984 Mar; 14(3):222-7. PubMed ID: 6200332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures.
    McHugh SM; Rifkin IR; Deighton J; Wilson AB; Lachmann PJ; Lockwood CM; Ewan PW
    Clin Exp Immunol; 1995 Feb; 99(2):160-7. PubMed ID: 7851006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defining promiscuous MHC class II helper T-cell epitopes for the HER2/neu tumor antigen.
    Kobayashi H; Wood M; Song Y; Appella E; Celis E
    Cancer Res; 2000 Sep; 60(18):5228-36. PubMed ID: 11016652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compositional bias and mimicry toward the nonself proteome in immunodominant T cell epitopes of self and nonself antigens.
    Ristori G; Salvetti M; Pesole G; Attimonelli M; Buttinelli C; Martin R; Riccio P
    FASEB J; 2000 Mar; 14(3):431-8. PubMed ID: 10698957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen-specific, MHC-restricted B cell activation by cell-free Th2 cell products. Synergy between antigen-specific helper factors and IL-4.
    Guy R; Hodes RJ
    J Immunol; 1989 Sep; 143(5):1433-40. PubMed ID: 2474597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model.
    Hosken NA; Shibuya K; Heath AW; Murphy KM; O'Garra A
    J Exp Med; 1995 Nov; 182(5):1579-84. PubMed ID: 7595228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells.
    Zarour HM; Maillere B; Brusic V; Coval K; Williams E; Pouvelle-Moratille S; Castelli F; Land S; Bennouna J; Logan T; Kirkwood JM
    Cancer Res; 2002 Jan; 62(1):213-8. PubMed ID: 11782380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.